Close
Smartlab Europe
Achema middle east

News

Turkish Cargo achieved the highest growth rate among the top 25 air cargo carriers

Turkish Cargo, the fastest growing air cargo brand in the world, achieved the highest growth rate among the best 25 air cargo carriers with 16.6 percent growth rate, according to the International Air Transport Association's (IATA) Freight Tonne Kilometers...

Leading CPO makes multi-million-pound investment in new packaging equipment

Leading pharmaceutical outsourcing partner, the Wasdell Group (Wasdell), has announced a multi-million-pound investment in new packaging equipment across its sites in the UK and Ireland. The company, which specialises in end-to-end supply chain services, made the decision to invest in...

Applied Biology in Collaboration with University Hospital Ramon y Cajal To Launch a Clinical Study to Identify Genetic Risk to COVID-19 Mortality

In a joint research effort studying the genetics of the androgen receptor in androgenetic alopecia, scientists discover a possible genetic variation that pre-disposes COVID-19 patients to develop severe symptoms. The team led by Andy Goren, MD Medical Researcher and...

AMRI Increases Hydroxychloroquine Sulfate API Production in U.S. to Meet Potential COVID-19 Demand

AMRI announced its ongoing commitment to do its part in support of public health needs amidst the COVID-19 pandemic. The company continues to focus on the safety of its employees, assuring supply of critical raw materials, active pharmaceutical ingredients...

Applied BioMath, LLC Announces Collaboration with Zymeworks

Applied BioMath, the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis to de-risk drug research and development, announced the continuation of their collaboration with Zymeworks Inc. Applied BioMath will design and deliver a systems pharmacology model...

Vaxart Announces Additional Positive Pre-Clinical Data for its Oral COVID-19 Vaccine Program

Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced that it has obtained positive pre-clinical results for its COVID-19 vaccine candidates, with several of the vaccine candidates generating...

Aridis Pharmaceuticals Enrolls Its First COVID-19 Patient in Ongoing Phase 3 AR-301 Clinical Trial in Ventilator Associated Pneumonia

Aridis Pharmaceuticals, Inc., a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening bacterial infections, announced the enrollment of its first COVID-19 patient in the Company's ongoing Phase 3 clinical trial of AR-301,...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »